"Can MSB benefit from this 'More Patient Focused and Less Adversarial' FDA review process?"
Should yes. But depends on any hidden agenda and who (BP) may be in the ear of the FDA.
Who knows what is happening behind the curtain.
V.
- Forums
- ASX - By Stock
- 2024 Here we go again.
"Can MSB benefit from this 'More Patient Focused and Less...
-
- There are more pages in this discussion • 214 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.12 |
Change
0.015(1.36%) |
Mkt cap ! $1.278B |
Open | High | Low | Value | Volume |
$1.13 | $1.16 | $1.10 | $7.169M | 6.411M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 7296 | $1.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.12 | 43068 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 7296 | 1.115 |
6 | 73021 | 1.110 |
4 | 158088 | 1.105 |
5 | 95283 | 1.100 |
5 | 215652 | 1.095 |
Price($) | Vol. | No. |
---|---|---|
1.120 | 43068 | 1 |
1.125 | 119746 | 3 |
1.130 | 89862 | 8 |
1.135 | 43282 | 3 |
1.140 | 106845 | 9 |
Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |